Welcia Holdings Co., Ltd. (TYO:3141)
2,476.50
-67.00 (-2.63%)
Apr 24, 2025, 3:30 PM JST
Welcia Holdings Revenue
In the fiscal year ending February 28, 2025, Welcia Holdings had annual revenue of 1.29T JPY with 5.56% growth. Welcia Holdings had revenue of 327.21B in the quarter ending February 28, 2025, with 6.63% growth.
Revenue
1,285.01B
Revenue Growth
+5.56%
P/S Ratio
0.41
Revenue / Employee
84.06M
Employees
15,286
Market Cap
527.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 28, 2025 | 1,285.01B | 67.67B | 5.56% |
Feb 29, 2024 | 1,217.34B | 73.06B | 6.38% |
Feb 28, 2023 | 1,144.28B | 118.33B | 11.53% |
Feb 28, 2022 | 1,025.95B | 76.30B | 8.03% |
Feb 28, 2021 | 949.65B | 81.37B | 9.37% |
Feb 29, 2020 | Pro | Pro | Pro |
Feb 28, 2019 | Pro | Pro | Pro |
Feb 28, 2018 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Shionogi & | 456.87B |